Will the Supreme Court Clarify Patent-Eligibility?


The United States Supreme Court is set to render its decision on the grant or denial of Sequenom, Inc.'s petition for writ of certiorari that posed the issue: Whether a novel method is patent-eligible where: a researcher is the first to discover a natural phenomenon; that unique knowledge motivates him to apply a new combination of known techniques to that discovery; and he thereby achieves a previously impossible result without preempting other uses of the discovery? As reported by BNA's Life Science and Industry Report , the Supreme Court held its last conference on June 23rd before adjourning for the summer, and the Sequenom petition is one of the yet-to-be released decisions from the 2016 judicial season.



from Biotech News